Factors associated with clinically relevant drug-drug interactions with statins in outpatients with coronary artery disease

Santos, Jéssica Nathália Domingos dos; Veloso, Ronara Camila Souza Groia; Tinoco, Marlon Silva; Reis, Adriano Max Moreira

doi:10.15343/0104-7809.202044506514

Mundo Saúde

2020

DOI: 10.15343/0104-7809.202044506514

|View full text |Cite

Factors associated with clinically relevant drug-drug interactions with statins in outpatients with coronary artery disease

Jéssica Nathália Domingos dos Santos¹,

Ronara Camila Souza Groia Veloso²,

Marlon Silva Tinoco³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Worldwide Prevalence of Polypharmacy: A Systematic Review

Januário,

Mafra,

de Souza Silva

et al. 2023

CDM

View full text Add to dashboard Cite

Introduction: The present study has compiled the prevalence of polypharmacy worldwide and assessed the prevalence of polypharmacy in different populations, including community-dwelling individuals, hospitalized patients, and institutionalized patients. Methods: This systematic review was conducted and reported according to the guidelines outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement. A systematic search of electronic databases, including PubMed, Web of Science, and Scielo, was performed in March 2021 without any date and language restrictions. Combinations of the following keywords were used for the search strategy: polypharmacy OR multiple medications OR multiple medicines OR multiple drug AND prevalence. Based on the search and inclusion criteria, two hundred and eight studies (73,076,167 individuals) were selected for inclusion in the systematic review. It was observed that there is a wide variation in the prevalence of polypharmacy between studies. Results: The prevalence of polypharmacy was found to be 30.2%, 61.7%, and 56.9% for community-dwelling individuals, hospitalized patients, and institutionalized patients, respectively. Conclusion: Based on the analyses, this systematic review has demonstrated a wide variation in the prevalence of polypharmacy between studies and countries and a high prevalence of polypharmacy in institutionalized and hospitalized patients.

show abstract

Worldwide Prevalence of Polypharmacy: A Systematic Review

Januário,

Mafra,

de Souza Silva

et al. 2023

CDM

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Factors associated with clinically relevant drug-drug interactions with statins in outpatients with coronary artery disease

Cited by 1 publication

References 13 publications

Worldwide Prevalence of Polypharmacy: A Systematic Review

Worldwide Prevalence of Polypharmacy: A Systematic Review

Contact Info

Product

Resources

About